Skip to content

The Effects of Oral Metronidazole Pill on Trichomonas Vaginalis Infection Treatment

A Comparison of the Effects of Oral Ferula Capsul and Oral Metronidazole Pill on Terichomonas Vaginalis Infection Treatment

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190220042776N1
Enrollment
60
Registered
2019-04-01
Start date
2019-04-09
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trichomonas vaginalis. Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

Interventions

Intervention 1: Intervention group1: Health Tips and Appropriate medicine consumption (twice a day, for seven days every 12 hours) are taught. Oral pills 500 mg of metronidazole is prescribed. After t

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Being Iranian To cooperate willingly Having at least the ability of reading and writing Being married Having sexual relationship with her spouse Not having Pelvic inflammatory disease (PID) She should use condom during the course of treatment Having no particular medical condition The total score for signs and symptoms of Trichomonas vaginalis is at least 1 in the examination and interview A wet specimen test being positive for Trichomoniasis Not having recurrent Trichomoniasis

Exclusion criteria

Exclusion criteria: Having sex without using condom during treatment There is no history of allergy to oral metronidazole tablets and Appiaceae Not using antibiotics or anti-parasites within two weeks Having abnormal uterine bleeding (AUB / DUB) Not using the treatment for one day or using twice a day Being pregnant

Design outcomes

Primary

MeasureTime frame
Negative result of Vaginal mucus test smear test of woman with Trichomonas vaginal infection. Timepoint: 2 and 7 days after the completion of the medication if it the person does not have period, otherwise if the sample experiences a monthly pattern after the end of the period. Method of measurement: Vaginal mucus wet smear test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Bagherinasab

Mashhad University of Medical Sciences

m_bagherinasab@yahoo.com+98 51 5523 5570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026